Manufacturer record
Events Corporation: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Events Corporation (Himachal Pradesh) were declared Not of Standard Quality between February 2023 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: EMVB-24162, Levamisole & Oxyclozanide Bolus Vet. (Wormizole Bolus) (exp Sep 2026). RDTL Chandigarh (CDSCO lab) found it not of standard quality: Disintegration test. Listed in the April 2025 alert.
Records by type
3 records linked to Events Corporation in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levamisole & Oxyclozanide Bolus Vet. (Wormizole Bolus) | Batch EMVB-24162Mfg Oct 2024 · Exp Sep 2026 | Disintegration testDisintegration | RDTL ChandigarhCDSCO lab | Apr 2025 |
| Pantoprazole Tablets I.P. (POP CARE-40), | Batch ET-22047Mfg Apr 2023 · Exp Mar 2024 | Dissolution of Pantoprazole in Acid stageDissolution | RDTL GuwahatiState lab | Sep 2023 |
| Albendazole Tablets IP (Altai 200 Tablets) | Batch EVT-22080Mfg Jul 2022 · Exp Jun 2024 | DissolutionDissolution | RDTL ChandigarhState lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.